Recombinant Human CCL13

Recombinant Human CCL13 is an agonist for CCR2, CCR3, and CCR5. This product is provided as 5μg of dry powder alongside reconstitution buffer.

Catalog #: 92-1003 Size: 5 µg


Biological Information
Background Information:
CCL13 is a cytokine protein involved in the induction of chemotaxis in monocytes, as well as eosinophils, T lymphocytes, and basophils, by acting as an agonist for cell surface receptors like CCR2, CCR3, and CCR5. It plays a role in leukocyte accumulation during inflammation. Activity of this protein has been linked to asthma and atopic dermatitis, and can be induced by the inflammatory cytokines, including interleukin-1 and TNF-α. Provided as 5 μg of dry powder alongside reconstitution buffer.
Target Class:
Target Name:
Product Type:
Recombinant Proteins
Drug Discovery & Development
Storage Conditions:
Store at ≤-20°C. Please avoid multiple freeze/thaw cycles.
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Additional Information


92-1003 Datasheet

View Document